From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting– a number needed to treat perspective
Crossref DOI link: https://doi.org/10.1007/s00432-025-06229-3
Published Online: 2025-06-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Orlandi, Armando
Text and Data Mining valid from 2025-06-09
Version of Record valid from 2025-06-09
Article History
Received: 23 April 2025
Accepted: 9 May 2025
First Online: 9 June 2025
Declarations
:
: The authors declare no competing interests.